Efficacy of Mirasol-treated Apheresis Platelets in Patients With Hypoproliferative Thrombocytopenia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This is a prospective, multi-center, controlled, randomized, non-inferiority study to evaluate the clinical effectiveness of Conventional versus Mirasol-treated apheresis platelets in subjects with hypoproliferative thrombocytopenia who are expected to have platelet count(s) ≤ 10,000/μL requiring ≥ 2 platelet transfusions.
Epistemonikos ID: 1fab959c8aea9fa727b938919219e9b3bf9e8865
First added on: May 17, 2024